Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China
· Delayed Price · Currency is CNY 5.55
-0.06 (-1.07%)
Apr 30, 2025, 3:04 PM CST
SHE:002412 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 173.24 | 220.24 | 205.01 | 167.62 | 134.85 | 106.15 | Upgrade
|
| Depreciation & Amortization | 40.76 | 40.76 | 50.83 | 51.59 | 51.19 | 50.04 | Upgrade
|
| Other Amortization | 0.72 | 0.72 | 0.85 | 0.71 | 0.71 | 0.7 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.02 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -1.78 | -1.78 | 0.27 | 47.52 | 40.96 | 27 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.97 | -9.97 | -62.95 | -92.71 | -68.3 | -53.87 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0.02 | 0.03 | -0.27 | -1.37 | Upgrade
|
| Other Operating Activities | 77.56 | 1.65 | 6.68 | 3.94 | 7.16 | 7.43 | Upgrade
|
| Change in Accounts Receivable | -110.32 | -110.32 | -61.77 | -35.83 | 14.34 | 67.43 | Upgrade
|
| Change in Inventory | 8.18 | 8.18 | 15.23 | -6.93 | -19.57 | 0.7 | Upgrade
|
| Change in Accounts Payable | -18.55 | -18.55 | 7.56 | 7.93 | 51.92 | -39.31 | Upgrade
|
| Operating Cash Flow | 159.69 | 130.78 | 160.95 | 143.81 | 212.54 | 163.51 | Upgrade
|
| Operating Cash Flow Growth | 43.86% | -18.74% | 11.92% | -32.34% | 29.99% | -2.55% | Upgrade
|
| Capital Expenditures | -11.15 | -11.64 | -19.48 | -11.5 | -229.34 | -129.08 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | 0.35 | 0.23 | 0.05 | 0.24 | Upgrade
|
| Investment in Securities | -128.44 | -38.27 | -64.44 | -96.07 | -48.84 | 9.76 | Upgrade
|
| Other Investing Activities | 7.28 | 7.71 | 22.01 | 33.85 | 106.49 | 0.5 | Upgrade
|
| Investing Cash Flow | -132.3 | -42.19 | -65.55 | -84.49 | -172.84 | -118.57 | Upgrade
|
| Short-Term Debt Issued | - | - | 105 | 150 | 131.62 | 178 | Upgrade
|
| Long-Term Debt Issued | - | 84.38 | - | - | - | - | Upgrade
|
| Total Debt Issued | 84.38 | 84.38 | 105 | 150 | 131.62 | 178 | Upgrade
|
| Short-Term Debt Repaid | - | - | -130 | -161.62 | -178 | -190.8 | Upgrade
|
| Long-Term Debt Repaid | - | -95 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -95 | -95 | -130 | -161.62 | -178 | -190.8 | Upgrade
|
| Net Debt Issued (Repaid) | -10.62 | -10.62 | -25 | -11.62 | -46.38 | -12.8 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1.35 | - | - | Upgrade
|
| Common Dividends Paid | -1.74 | -2.55 | -154.67 | -4.07 | -6.58 | -45.38 | Upgrade
|
| Other Financing Activities | -3 | - | - | 0.12 | 0.02 | 0.2 | Upgrade
|
| Financing Cash Flow | -15.36 | -13.17 | -179.67 | -14.22 | -52.95 | -57.98 | Upgrade
|
| Net Cash Flow | 12.02 | 75.42 | -84.28 | 45.09 | -13.25 | -13.05 | Upgrade
|
| Free Cash Flow | 148.54 | 119.15 | 141.47 | 132.3 | -16.8 | 34.42 | Upgrade
|
| Free Cash Flow Growth | 60.69% | -15.78% | 6.93% | - | - | -73.94% | Upgrade
|
| Free Cash Flow Margin | 14.57% | 11.86% | 14.80% | 14.44% | -1.88% | 4.64% | Upgrade
|
| Free Cash Flow Per Share | 0.29 | 0.24 | 0.28 | 0.26 | -0.03 | 0.07 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.08 | 0.19 | - | Upgrade
|
| Cash Income Tax Paid | 183.73 | 192.73 | 174.93 | 104.01 | 102.21 | 108.46 | Upgrade
|
| Levered Free Cash Flow | 75.99 | 44.94 | 81.48 | -25.92 | 49.24 | -46.03 | Upgrade
|
| Unlevered Free Cash Flow | 75.99 | 44.94 | 83.78 | -23.48 | 53.32 | -41.48 | Upgrade
|
| Change in Net Working Capital | 109.5 | 136.45 | 56.68 | 147.55 | -151.92 | 16.94 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.